Strides Shasun’s active pharmaceutical ingredients (API) manufacturing site in Puducherry was recently inspected by the United States Food and Drug Administration (US FDA) and the approval was renewed with ‘Zero 483’ status. Over the last month, three facilities were inspected by US FDA and cleared with Zero 483 Status.
The Company’s flagship Facility (KRSG Gardens) in Bangalore was also inspected and cleared by US FDA in June 2016 without any ‘Zero 483’ observations. With this, the company’s last four US FDA inspections were successfully completed without any observations.
Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and semi-solids.